decisionhealth Newsletters, Coder Pink Sheets - 2022 Issue 2 (February)
New coding guidance: Epidural steroid injection notice requirement is simpler than it sounds
Subscribe or sign in to view the full article.
Article Overview
This article is for pain management, coding, and billing professionals who work with Medicare coverage guidance for epidural steroid injections. It discusses a local coverage determination, a recent clarification discussed in webinar and comment-period language, and the practical documentation and notification issues practices may face when treating patients over an extended period. The article also places the notification topic in the context of other coverage limitations and the possibility of medical review when treatment extends beyond the usual timeframe.
Why This Topic Matters
Coverage requirements for epidural steroid injections can affect documentation, communication workflows, and medical review risk. Understanding the notification expectation and related limitations helps practices align their records with Medicare policy without overstepping into unnecessary approvals or unsupported assumptions.
What You Will Learn
- What Medicare coverage guidance says about prolonged epidural steroid injection treatment
- How the notification topic fits within the broader coverage limitations
- What kinds of documentation practices are discussed as evidence of notice
- Which circumstances are described as relevant to continuing treatment under the coverage policy
- Why extended treatment courses may attract additional review
Who Should Read This
- Pain management clinicians
- Medical coders
- Medical billers
- Revenue cycle staff
- Compliance staff
- Practice administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com